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Abstract
Rationale: Cone Beam Computed Tomography imaging has become increasingly important in
many fields of interventional therapies. Objective: Lung navigation study which is an uncommon
soft tissue approach. Methods: As no effective organ radiation dose levels were available for this
kind of Cone Beam Computed Tomography application we simulated in our DynaCT (Siemens
AG, Forchheim, Germany) suite 2 measurements including 3D acquisition and again for 3D acquisition and 4 endobronchial navigation maneuvers under fluoroscopy towards a nodule after the
8th segmentation in the right upper lobe over a total period of 20 minutes (min). These figures
reflect the average complexity and time in our experience. We hereby describe the first time the
exact protocol of lung navigation by a Cone Beam Computed Tomography approach. Measurement: The hereby first time measured body radiation doses in that approach showed very
promising numbers between 0,98-1,15mSv giving specific lung radiation doses of 0,42-0,38 mSv.
Main results: These figures are comparable or even better to other lung navigation systems.
Cone Beam Computed Tomography offers some unique features for lung interventionists as a
realtime 1-step navigation system in an open structure feasible for endobronchial and
transcutaneous approach. Conclusions: Due to this low level of radiation exposure Cone Beam
Computed Tomography is expected to attract interventionists interested in using and guiding
endobronchial or transcutaneous ablative procedures to peripheral endobronchial and other lung
lesions.
Key words: Dyna CT, lung cancer, diagnosis.
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Introduction
Cone Beam Computed Tomography (CBCT)
imaging has become increasingly important during
lung navigated interventions, demonstrating a fact
that is correlated with modern endoscopic and image-guided diagnostic and/or therapeutic modalities
addressing thoracic malignancies.[1-11] First reports
on medical navigation during thoracic surgical procedures such as from the SHG Hospital Voelklingen,
Germany and University Hospital, Saga, Japan (Customer Magazine AXIOM Innovations November,
2012) paved the way to advanced thoracic operative
theaters in that they allow multimodal interventional
approaches. However CBCT navigation carries an
additional radiation exposure to patient and operator,
which has not been measured or published for lung
procedures to this day. Modern CBCT configurations
allow the standard 2-dimensional (2D) projection
functionality like fluoroscopy as well as volumetric
computed tomography (CT) capabilities within the
interventional suite. For acquisition of the
3-dimensional (3D) dataset the C-arm of CBCT needs
to rotate by at least 200° (180° plus fan angle) around
the target that has to remain stationary during acquisition.[12] For our lung image acquisition we use the 5
seconds (s) run with 248 single 2D-projections with a
30cm*40cm head. Our protocol is providing sufficient
image quality for clearly displaying the bronchial
structures as well as the target itself. (Figure 1) These
data are sent automatically to a workstation where the
reconstruction is completed within less than 15s. At
the workstation the target itself as well as the path
within the bronchial tree are identified and marked
with manual annotation tools (Siemens iguide
toolbox). Afterwards these markers are projected and
overlaid to the fluoroscopic image. (Figure 2) This
technique allows the physician to match his instruments to the overlay and in consequence navigate
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correctly to the (sometimes fluoroscopy-invisible)
target. The major limitation of this technique is significantly poorer image quality if there is target motion during 3D acquisition. For eliminating this factor
the absence of spontaneous respiration is mandatory –
the patient has to be put into apnea. The connected jet
ventilation system (TwinStream, Carl Reiner, and
Austria) is maintaining the inspiration phase during
acquisition and navigation process. This leads to an
accurate match between the 3D dataset and the
fluoroscopic image. At the same time maintained inspiratory ventilator set-up with high inspiratory
pressures (e.g. at least over 2,5bar) over e.g. 12s hyperinflates the lung. This offers good visualization of
bronchioli smaller 3mm in diameter after the 7th-8th
segmentation. (Figure 3, 4) When used in normofrequent jet-ventilation (e.g. jet-ventilation with respiratory frequency (RF) 80/min with inspiration-exspiration ratio (I: E) of 1:1,5) standard inspiratory working pressures (SIWP) initially are set up
along the weight of a patient: (SIWP) (bar) = (weight
(kg)*0,015) with a fractional inspiratory oxygen concentration (FIO2) 0,8-1. To perform 3D data acquisition under hyperinflation it is necessary to change the
set-up of the ventilator to RF 2/min with an I: E 3:1
giving at least 15s of maintained hyperinflation
without any movement: During this period there is
perfect alignment between the virtual anatomy derived from the 3D data acquisition overlaid in fluoro
imaging and the real anatomy. To reach the optimal
hyperinflation the SIWP is elevated in steps of 0,5bar
until a peak inspiratory pressure (PIP) measured at
the tip of the double lumen jet-catheter (Acutronic,
Medical Systems, Switzerland) reaches 40mbar. (Figure 5) The positioning of the jet-catheter is performed
by seldinger technique with use of a pulmonary
jag-wire (Boston Scientific, USA).

Figure 1. A) DynaCT with a bit of motion artefact, B) Right: HRCT 1mm nearly same level; slices same patient (2 adeno-carcinomas: *) Showing the same
nice details (arrows at the same position indication bronchioli of 2mm and less).
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Figure 2. A) DynaCT with carcinoid*Arrows indicating small bronchioli subpleural. B) Right: iguide toolbox with the same dataset before annotation of the
path and target volume.

Figure 3. A) Dotting the pathway in the 3 standard axis, B) Segmentation and dotting of the SPN in the 3 standard axis, C) Overlay in fluoroscopy (different
patients).
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Figure 4. An example of navigation up to a SPN after the 8th segmentation (counted from the main carina).

Figure 5. Jet-catheter inserted in trachea in DynaCT (arrows).

Materials and Methods for radiation exposure measurements
The male Alderson-Rando phantom (The Phantom RANDO®, Alderson Research Laboratories Inc.,
Stamford, CT, USA) (mARp) is an anthropomorphic
phantom which can be equipped with dosimeters.

(Figure 6.) It consists of a human skeleton which is
embedded in a rubber composition with isocyanate
having a specific density of 0.985 g/cm ³ along with
absorption and scattering properties to X-rays equivalent to those of the human tissue.
The height of the limb-less body phantom is 173
cm, its weight amounts 73.5 kg. The sagittal diameter
http://www.jcancer.org
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of the abdomen measures 22 cm. The phantom can be
disassembled into 2.5 cm thick, axial slices. Each layer
is provided with holes meant for holding dosimeters.
These dosimeters are thermoluminescense detectors
(TLD). These detectors are based on the emission of
thermoluminscence (TL) on heating of previously
exposed crystalline materials. The intensity of the
emitted TL is a function of the dose deposited in the
material, and can therefore be used for dosimetry.

Calibration of TLD
In TLD with the same time-radiation history i.e.
always irradiated, analyzed and regenerated together
at the same time, the change in the calibration factor is
approximately equal.
Therefore, the TLDs are summarized in batches
which always pass together through a measurement
cycle. A batch is always divided into two fractions
during a measurement. The first fraction (F1) is subjected to a calibration irradiation at a defined dose (1
Gy) to determine the change in the calibration factor.
This change of calibration factor can be applied to the
second fraction (F2) which is used for the actual
measurement of the radiation dose.
As a TLD for the organ dose measurements
serves Lithium-Fluorid-thermoluminescence dosimeters (The Harshaw Chemical Company, Chrystal and
Electronics Products Department, Solon, Ohio, USA)
(TLD-100 rods, 1 x 1 x 6 mm). The locations are selected on the basis of a CT atlas. Three TLD rods were
packed in plexiglass tube and then inserted into the
corresponding holes of the respective layer of the
mARp. For dose measurements with the mARp 150
TLDs were fitted to 43 different measuring points.

TLD-Reader
The
TLD
rods
were
stabilized
C
("pre-annealing") and analysed in the next hours following the investigation for 10min at 100°. The TLD
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reader used is an analyzer type Harshaw. For these
analyses the TLDs are placed in an evaluation unit
which provides at the same time for heating and for
transmitted light detection during the heating process. For light detection photomultiplier (PM) are
used. The electric current generated by transmitted
light during the heating process is proportional to the
amount of light emitted from the TLD. Before each
measurement a current measurement under dark
conditions is carried out to ensure a constant PM sensitivity. The dosimeters are heated in 20 s with a linear
increase in temperature to 270°C. The measured values are adjusted by the background radiation, which
is determined by fraction F1 of each TLD-rod batch.
Each organ dose results from the average of the adjusted data from the three TLD rods per measurement
point. A backscatter correction of the measured values
for the dose is performed. From the different measured values of organ doses finally the effective patient
dose is calculated.

Calculation of the effective patient dose
The effective dose (otherwise known as the effective dose equivalent) is a measure of radiation exposure of humans. To calculate the effective dose
(Deff) the organ doses (HT) are multiplied by the tissue weighting factor (wT) of each organ (T). The sum
of such weighted organ doses results in the effective
(whole body) dose in Sievert (Sv):

The tissue weighting factors were used by us in
accordance with the current recommendations of the
International Commission on Radiological Protection
(IRCP). [13] The dose-area product has been stored for
the entire investigation.

Figure 6. The male Rando Alderson phantom 3edge angulations with 3 different views at least 30 degrees different to each other and with one oblique
view.

http://www.jcancer.org
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Dose-Area product (DAP)
The DAP was recorded using a panel attached to
the ionization measurement chamber and by a reader
(Diamentor M3, PTW, Freiburg, Germany) the value
appeared in "cGycm²".
It is calculated by multiplying the ionization in
air (air kerma [cGy]) in the measurement chamber
with the irradiated area [cm²]. The DAP and the
fluoroscopy time were recorded separately for the
above mentioned subsequent simulated investigation
over 20min. Furthermore, the kV and mA values were
recorded.
Our standard protocol of specific jet-ventilation
with deep sedation in complete apnea for the purpose
of CBCT guided endobronchial navigation consists of
the following steps:
1. Seldinger-technique for jet-catheter positioning in the middle part of the trachea.
2. Initiation of sedation protocol to achieve very
low frequency of spontaneous breathing near apnea
with
remifentanil(0,05ug/kg/min)
and
propofol-perfusors (4mg/kg/h). For definite apnea
during data acquisition we used additional boli of
50mg propofol. In case of low blood pressure we applied saline 0,9% and sometimes akrinor (Ratiopharm,
Germany; 2ml consists of cafedrinhydrochlorid
200mg and theodrenalinhydrochlorid 10mg as main
drugs), in case of low heart frequency less than
50/min we applied atropine (B. Braun, Germany;
0,5mg/ml).
3. Bronchoscopic control of the jet-catheter position after nasal fixation to avoid direct objection
against any endoluminal obstacle and introduction of
an oral Guedel tube to keep pharynx and mouth open.
4. Application of the above mentioned low frequency inversed ratio jet-catheter set-up with FIO2
100% and uptitration of the SIWP up to a PIP of
40mbar. The maximum allowed SIWP is 3,5bar. By
this means we achieve maximal tolerable hyperinfiltration.
5. Establishing complete apnea by the use of additional propofol boli for data acquisition under constant hyperinflation with CBCT.
6. Annotation of the path and the target with the
Siemens toolbox and overlay of this 3D-information in
the fluoroscopy image.
7. In a situation of navigational decision the same
ventilator set-up as during data acquisition has to be
applied in order to guarantee perfect alignment of the
virtual path and target volume with natural anatomy.
8. Navigation control is achieved by the so called
3-edges-angulation during this period of perfect
alignment. From a posterior-anterior position of the
DynaCT-head one has to angulate thirty degrees lat-
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eral, then follow with another angulation of thirty
degrees caudal or cranial and finally angulate thirty
degrees medial. (Figure 7.) The examiner has to compare these 3 views of the used endobronchial probe
under fluoroscopy with the virtual anatomy overlaid
in the fluoroscopy image: If we observe that the probe
in all views stays in the virtual path segmentation or
the target volume we can conclude that it has reached
the desired anatomical position endothoracically. The
number of 3-edges angulations needed depends on
the complexity of the path and the endoluminal entry
into the target. During the examination time when no
navigational decision is needed we apply normofrequent jet-ventilation (e.g. RF 80/min; I: E 1:1, 5; SIWP
in regards to blood gases).
9. Biopsy is performed within the second of the
manual stop of the ventilator set-up to avoid peripheral pneumothorax under hyperinflation. Repeated
biopsies are done without additional 3-edgesangulations via an applied sheath which was used
with first biopsy put over the instrument.

Figure 7. 3edge angulations with 3 different views at least 30 degrees
different to each other and with one oblique view.

Results
With the following standard program on our
ceiling-mounted Artis Zee we found a whole body
effective radiation dose of 0,98mSv under CBCT data
acquisition for a SPN in the RUL. Adding 4 maneuvers of endobronchial lung navigation towards a SPN
after the 8th segmentation in the RUL over 20min this
dose increased to 1,15mSv for acquisition and navigation. (Tables 1, 2)
Coro 40 Log Dyna CT Cardiac; 5sec untriggered;
91kV,344mA, 3,9ms,1859,9µGym², 62,6mGy: 0,98-1,15
mSv

http://www.jcancer.org
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Table 1. Measured radiation doses in the mARp during acquisition.
Organ
brain
thyroid
lung
bone marrow
esophagus
thymus
breast
liver
stomach
spleen
adrenal glands
pancreas
left kidney
small intestine
colon
ilopsoas muscle
ovar / testes
uterus
bladder
bone surface
skin
other organs
total

Organ dose
(mSv)
0,14
1,03
3,53
1,94
4,47
4,00
0,00
0,14
0,11
0,05
0,15
0,12
0,07
0,00
0,00
0,00
0,00
0,00
0,00
0,38
0,40
0,56

Weighting
factor
0,01
0,04
0,12
0,12
0,04
0,01
0,12
0,04
0,12
0,01
0,01
0,01
0,01
0,01
0,12
0,01
0,08
0,01
0,04
0,01
0,01
0,06
1,00

Effective dose
(mSv)
0,001
0,041
0,424
0,233
0,179
0,040
0,000
0,006
0,013
0,001
0,002
0,001
0,001
0,000
0,000
0,000
0,000
0,000
0,000
0,004
0,004
0,034
0,982

Table 2. Measured radiation doses in the mARp during acquisition and 4 navigation maneuvers towards a SPN in the RUL after
the 8th segmentation.
brain
thyroid
lung
bone marrow
esophagus
thymus
breast
liver
stomach
spleen
adrenal glands
pancreas
left kidney
small intestine
colon
ilopsoas muscle
ovar / testes
uterus
bladder
bone surface
skin
other organs
total

0,17
6,34
3,18
1,83
4,48
4,86
0,00
0,10
0,08
0,03
0,05
0,08
0,05
0,03
0,03
0,03
0,06
0,00
0,01
0,28
0,30
0,66

0,01
0,04
0,12
0,12
0,04
0,01
0,12
0,04
0,12
0,01
0,01
0,01
0,01
0,01
0,12
0,01
0,08
0,01
0,04
0,01
0,01
0,06
1,00

0,002
0,254
0,382
0,220
0,179
0,042
0,000
0,004
0,010
0,000
0,000
0,001
0,000
0,000
0,004
0,000
0,005
0,000
0,000
0,003
0,003
0,041
1,147

Discussion
There is a high need for navigation in the lung to
improve the diagnostic yield for SPNs, especially for

SPNs < 3 cm or for fluoroscopy transparent nodules
[14] where conventional bronchoscopy shows very
limited diagnostic yield. This is in contrast to the fact
that the principle rule’’ the earlier the diagnosis, the
better the prognosis of an oncologic disease’’ especially counts for the size of an incidental lung cancer
according to current guidelines.[15] Different electromagnetical navigation (EMN) techniques for endobronchial approach have been developed in the last
years aiming to improve the diagnostic yield. They
are based on a low power magnetic resonance field in
which the patient with magnetic sensors fitted instruments is explored by the help of a preceeding
CT-data-acquisition.[16-19]
This
preceeding
CT-dataset is overlaid and corrected by typical landmarks (e.g. carinas) of the existing anatomy given by
realtime bronchoscopy views. By this fusion and the
identification of the instrument position in the
3-dimensional volume this technique can produce
’’realtime’’ virtual anatomy pictures beyond central
airways which is then processed in a way to increase
the ability of examiners to reach distal SPNs. It has
been shown that EMN bronchoscopy provides a superior diagnostic yield of 59-74% in SPN compared to
standard transbronchial biopsy with an acceptable
rate of complications mainly pneumothorax. [16-23]
Diagnostic yield can be increased if a radial ultrasound probe is used to visualize the lesion and
therefore prove that the tip of the extended working
channel ends in the target zone. [16] An additional CT
has to be performed as most of the CT scans during
the initial diagnostic work-up do not fulfill the criteria
necessary for EMN systems. In the end an EMN procedure is a 2-steps method: Data acquisition does not
take place in the same examination set-up as for taking biopsies or local treatment. Most EMN systems do
not offer a transthoracical approach. High acquisition
and maintenance costs prevent a wide spread of this
technique until now. From our view there are the following substantial differences between 2-steps EMN
methods and real-time extrathoracical 1-step
CBCT-navigation:
Firstly, in EMN bronchoscopy the essential preceding CT-dataset is an additional radiation exposure
for the patient which is higher than the radiation exposure by CBCT navigation in average (Table
3,4,5,6,7.) Secondly, the major disadvantage of a 2
steps-method is the fact that the preceeding
CT-dataset is made during deep inspiration bending
down the diaphragm for a susbtantial height of several centimeters especially for SPNs in the lower
lobes. This position of the diaphragm is completely
different to the situation under conventional or navigated bronchoscopy by the help of the above mentioned systems as bronchoscopies are performed unhttp://www.jcancer.org
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der deep sedation in reduced spontaneous breathing
pattern which normally elevates the diaphragm until
the functional residual capacity of the patient’s lung is
reached. This means a great difference between the
preceeding dataset and real-time true anatomy due to
diaphragm recoil. Although there are efforts in some
EMN systems (like Veran Technology) to compensate
respiratory movement during navigation it is still a
2-steps method. Thirdly, the proceeding CT-dataset is
not performed on the same table at the same time in
the same organ and patient position in the same place
as with our protocol with CBCT. In case there is no
organ and patient movement there is in principal
perfect alignment of virtual 3D-dataset of
CBCT-acquisition and realtime true anatomical positon during endobronchial navigation. Moreover; extrathoracical navigation by CBCT for endobronchial
purpose is delivering the possibility of using the
’’unoccupied’’ working channel of bronchoscopes for
conventional instruments. Our method with CBCT
can perform continous endobronchial guidance and at
the same time allow regular bronchoscopy performances and maybe in future endobronchially driven
ablative local therapies. Furthermore, EMN navigation does not offer a CT-similar function for transthoracical approach as CBCT does: One may choose in
regards to the localisation of a SPN the access – endobronchial or transthoracical. Concerning additional
radiation exposure to patients the hereby first time
measured effective whole body radiation dose as
mentioned above is in comparison to other
CT-applications in chest medicine a very low figure.
Possible explanations for this very low figure could be
attributed to the following:
Firstly, an excentric patient position for imaging
of one (right) lung which would have induced less
radiation exposure. During our simulation at the
phantom we clearly averted this faulty position. Sencondly, in MSCT-acquisition the whole body diameter
of a patient is exposed to radiation which is not true
for CBCT-acquisition: The restriction by the geometry
of the flat panel detector and the zoom-factor causes
the so called field of view which is a cylindric volume
of a certain diameter smaller than the normal whole
body volume. This reduces again radiation exposure.
Thirdly, as the most navigation cases take place in the
right lung the dose measurements were performed for
right lung upper field. One has to remember that effective dose is based on x-ray sensitivity of organs.
Right lung is located away from stomach (with tissue
factor 0,12) and close to liver (tissue factor 0,05). This
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makes in the end a reduction of a few percentages of
the whole body effective radiation dose. Compared to
other thoracic CBCT applications such dose is quite
low [24] and allows from a radiation hygienic point of
view to use this technique generously for evaluation
and treatment of thoracic lesions. This dose is at least
1/3 less than the dose that was used in the National
Lung Screening Trial (NLST) in the United States.[25]
Compared to conventional CT guidance for transthoracic approaches CBCT navigation reduces the radiation exposure up to 42% during transcutaneous approach.[26] The use of endobronchial navigation for
bronchoscopic tissue biopsy in a conventional multi-slice CT with low-dose protocols (MDCT) is comparable in radiation effective organ doses to
patient.[27, 28] (Table 3.) Conversely to the closed
MDCT configuration, the open CBCT structure allows
for an easy access to the patient giving an advantage
in coping with possible interventional complications.
The hereby first time described technique has the potential to improve the determination and treatment of
smaller incidental solitary pulmonary nodule (SPN)
that are partially invisible under conventional fluoroscopy compared to the results of conventional
bronchoscopy. [14] In the future we believe that CBCT
guided interventions will be the standard of care for
any kind of focal procedures like endoluminal or
endovascular navigation, transthoracical or endoluminal thermal ablation, local chemotherapy or other
minimal-invasive procedures – in surgical or
non-surgical interventional settings. Besides the
above mentioned approaches in CBCT guided thoracical surgery some approaches have been made in
the last years in different new therapeutic fields [1,
29]. Very recently the combination of electromagnetic
navigation devices and common CT-technology
showed higher efficacy in transthoracical lung ablation procedures compared to standard CT-guidance
alone [30]. One can assume that this combination may
improve the qualities of CBCT-guided interventions
in future in a similar way. A CBCT-suite should be
used by all kinds of interventional departments. Due
to his qualities in 2D- and 3D-imaging, fusion capabilities, local flexibility and patient friendly
easy-to-access feasibility it will be the central part of
hybrid rooms. It may be therefore an instrument to
urge different medical specialties to cross over their
very individual borders of interventional knowledge
in the sense of real translational medicine: Get together in the CBCT-suite and take the best of all interventional worlds.

http://www.jcancer.org

Journal of Cancer 2014, Vol. 5

200

Table 3. Examples of (mean) effective total body doses in examination types of heart, lung, head and abdomen (soft tissue) with CBCT
or conventional XR- or CT-technique.
Examination type
Heart (EP), 30cm*40cm head CBCT (biplane)
(only 3D-data acquisition)
Heart (EP), XR guided
Heart (EP), XR guided, normal weight
Heart (EP), XR guided, overweight
Heart (EP), XR guided, obese
Lung (MDCT) (*)
Lung (standard thoracic CT, MSCT)
Triple-rule-out CT-angiography, 256-MSCT
Head protocol, CBCT (2 different systems)
Head protocol, MDCT
Abdomen, 2 protocols each, CBCT (2 different systems)
Abdomen, 2 protocols, MDCT
Percutaneous transthoracic needle biopsy of pulmonary nodules < 1cm, CBCT
Endobronchial lung navigation (MDCT)
Endobronchial lung navigation, 30cm*40cm head CBCT

mean eff. patient dose (mSv)
6,6

Ref.
24

8,3 (per hour)
15,2 (per 5,3 hour)
26,7 (per 5,3 hour)
39,0 (per 5,3 hour)
2
7-8
6,5(male)-3,8(female)
4,4-5,4
4,3
15-37
9,8-13,5
5,72mSv
0,55-0,7
0,98-1,15

7
8
8
8
12
11,12,26
6
9
9
9
9
10
28
our study

EP: Electrophysiology. XR: Fluorscopy. (*) National Lung Screening Trial in the USA. MSCT (multiple slice CT). MDCT (multiple slice low-dose CT).

Table 4. Examples of mean effective patient doses in milisievert (mSv) in classical XR-guided interventions consisting of radiography and
repeated fluoroscopy.
Examination type
Abdominal angiography
Arteriography of lower limbs
Biliary drainage
Embolization of spermatic vein
Nephrostomy

Radiography
3,1
3,8
1,8
0,4
0,9

Fluoroscopy
5,1
2,4
36,4
16,9
12,7

Total radiation exposure
8,2
6,2
38,2
17,3
13,6

Table 5. Effective doses of different organs in orthopedics / trauma surgery: Comparison of conventional XR guided approach vs.
CBCT-navigated approach.
Spine surgery
Organ
ovar
testis
red bone marrow
sigmoid/Rectum
lung
stomach
bladder
liver
esophagus
thyroid
Bone surface
others
Adrenal gland
brain
small bowel
kidney
pancreas
spleen
thymus
colon

CBCT navigated
0,03
0,04
0,61
0,05
0,03
1,55
0,07
1,18
0,02
0,00
0,46
1,02
1,15
0,00
1,43
1,79
1,09
2,59
0,00
1,16

XR guided conventional
0,97
0,83
22,48
2,22
0,17
8,28
3,47
3,30
0,09
0,09
1,68
10,47
4,68
0,02
31,14
13,26
4,79
16,96
0,06
22,32

Sacroiliac joint
CBCT navigated
0,45
0,16
2,31
1,23
0,04
0,08
0,32
0,07
0,04
0,01
0,16
0,38
0,10
0,00
0,28
2,35
0,09
0,16
0,02
2,07

XR guided conventional
4,59
0,79
14,39
3,24
0,14
0,23
1,88
0,33
0,08
0,02
0,79
1,14
0,40
0,03
0,92
0,74
0,30
0,43
0,06
2,82
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Table 6. Effective total body doses in different phantoms on a biplane CBCT.

Clifford
Braden
Alderson

Programs on Axiom Artis, syngo DynaCT 20*20cm2 biplane flat panel CBCT
5sDRc without grid
5sDRc with grid
Low Dose 5sDR-L 0,2Cu (with grid)
male
female
male
female
male
female
0.192
0.272
0.219
0.326
0.050
0.072
0.205
0.272
0.315
0.392
0.058
0.068
0.730
0.282

The effective dose according to ICRP103 separate for each program, phantom and gender. The values are given in milli Sievert (mSv). Clifford and Braden are hermaphrodite, Alderson is a male phantom. Alderson did not undergo the 5sDRc diagnostic program without grid.
A 10kg model “Clifford” represents children with an age of 0.5-3 years.
A 19kg model “Braden” represents children with an age of 3-7 years.
A 73kg model “Alderson” represents an adult person (as in our study).

Table 7. Effective organ doses on Axiom Artis, syngo DynaCT, 20*20cm2 biplane flat panel CBCT in different phantoms.
Organ/tissue

brain
thyroid
lung
red bone marrow
esophagus
thymus
breast
liver
stomach
spleen
adrenal gland
pancreas
left kidney
small intestine
colon
ovary
testis
uterus
urinary bladder
bone surface
skin
remainder organs

Clifford
5sDRc
without
grid
0.04
0.75
0.87
0.09
0.78
0.87
0.65
0.03
0.03
0.06
0.07
0.05
0.03
0.02
0.01
002
0,00
0.01
0.01
0.05
0.05
0.15

5sDRc
with grid
0.03
0.33
1.19
0.12
0.60
1.10
0.88
0.03
0.04
0.10
0.09
0.12
0.06
0.03
0.02
0.02
0.00
0.01
0.01
0.17
0.17
0.20

Low Dose
5sDR-L 0.2Cu
(with grid)
0.00
0.19
0.23
0.02
0.20
0.22
0.19
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.02
0.02
0.04

Braden
5sDRc
without grid

5sDRc
with grid

0.01
0.06
0.89
0.31
1.06
0.90
0.64
0.03
0.02
0.02
0.03
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.12

0.02
0.08
1.28
0.47
1.50
1.25
0.83
0.08
0.08
0.06
0.06
0.08
0.03
0.02
0.04
0.00
0.00
0.00
0.00
0.01
0.00
0.19

Conclusions
CBCT with DynaCT Artis Ceiling system for
endobronchial navigation in the lung is adding a
comparable low radiation exposure to the diagnostic
process of possible malignancy in the lung. It is offering some unique features like 1-step method of
acquiring and applying the 3-dimensional dataset at
the same time on the same table in the same place in
comparison to EMN techniques. As an extrathoracical
approach this system can be used to control as well
therapeutic procedures endobronchially or transthoracically performed under realtime guidance. The
open structure of a DynaCT is another advantage over
closed MDCT-navigation-systems. Therefore the high
feasibility as true multifunctional realtime navigation
tool for diagnostic and therapeutic purposes justifies a

Low Dose
5sDR-L 0.2Cu
(with grid)
0.00
0.03
0.23
0.09
0.32
0.25
0.15
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
0.00
0.00
0.00
0.00
0.03

Alderson
5sDRc
with grid
0.00
0.08
2.87
1.29
3.86
1.03
0.17
0.18
0.11
0.19
0.16
0.09
0.00
0.01
0.00
0.00
0.00
0.00
0.99
0.98
0.20

Low Dose
5sDR-L 0.2Cu
(with grid)
0.01
0.01
1.21
0.51
1.24
0.45
0.06
0.07
0.02
0.07
0.05
0.05
0.00
0.00
0.00
0.00
0.00
0.00
0.38
0.38
0.07

widespread use even with low additional patient’s
radiation exposure.
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